[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613809":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":29,"responsibleParty":44,"collaborators":11,"id":48,"slug":11,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":11,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":11,"enrollmentInfo":55,"targetDuration":11,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Thiazides treatment arm","ACTIVE_COMPARATOR",null,[13],"Drug: Hydrochlorothiazide 25mg once per day",{"label":15,"type":16,"description":11,"interventionNames":11},"Control arm","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DRUG","Hydrochlorothiazide 25mg once per day","Thiazides diuretics",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Gordon Chan, MD, MRCP","CONTACT","0085235052211","cck295@ha.org.hk",[30],{"facility":31,"status":32,"city":33,"state":11,"zip":11,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Prince of Wales Hospital. The Chinese University of Hong Kong","RECRUITING","Hong Kong",{"type":35,"coordinates":36},"Point",[37,38],114.17469,22.27832,{"lat":38,"lon":37},[41],{"name":42,"role":26,"phone":27,"phoneExt":11,"email":43},"CC Szeto, MD, FRCP","ccszeto@cuhk.edu.hk",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Chan Chun Kau Gordon","Dr","100613809",false,"NCT07271420","Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients","Inclusion Criteria:\n\n* Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \\>140 mmHg and\u002For DBP \\>90 mmHg)\n\nExclusion Criteria:\n\n* Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months","ALL","18 Years",{"count":56,"type":57},40,"ESTIMATED","INTERVENTIONAL",[60],"PHASE4","To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis",[63,64,65],"Hypertension","Peritoneal Dialysis","End Stage Kidney Disease (ESRD)",[63,21,67,68],"End stage kidney disease","Peritoneal dialysis","2025-11-26",{"date":71,"type":72},"2025-12-09","ACTUAL",{"date":74,"type":72},"2020-01-01",{"date":76,"type":57},"2027-06-30",{"name":5,"class":6},1]